Latest SenzaGen News & Updates

See the latest news and media coverage for SenzaGen. We track all announcements, press releases, and industry mentions in real time, all in one place.

SenzaGen

Non-animal toxicology testing, biocompatibility services, and regulatory consulting

senzagen.com

Headquarters: Lund, Sweden
Founded year: 2010
Company type: Public company
Number of employees: 21–50
Industry: Biotechnology & Medical Research

Last updated October 28

Latest news about SenzaGen

In short: SenzaGen acquired Alcyomics and posted 13% Q2 revenue growth

Company announcements

October 28 SenzaGen

SenzaGen acquires Alcyomics to expand non-animal testing services

The acquisition strengthens SenzaGen's position in drug development. Financing involves SEK 25 million in convertible bonds from Eiffel Investment Group.

August 20 SenzaGen

SenzaGen reports 13% growth and positive cash flow in H1 2026

Revenue rose to SEK 15.3 million in Q2 2026 with positive operating cash flow. VitroScreen received major orders amid EU plans to phase out animal testing.

August 13 SenzaGen

SenzaGen celebrates OECD respiratory sensitization NAM advancement

The OECD report reviews current mechanistic understanding and regulatory needs, and discusses GARDair's role. SenzaGen contributed via Dr. Andy Forreryd and an international expert group.

June 5 SenzaGen

SenzaGen says EU roadmap boosts its long-term market potential

The European Commission's plan prioritizes sensitization testing fully by 2029, increasing demand for SenzaGen's GARD tests.

Media coverage

October 28 MarketScreener

SenzaGen : acquires Alcyomics, a leading UK-based provider of non-animal immunotoxicology solutions for drug development

CET SenzaGen AB - Inside information SenzaGen acquires Alcyomics, a leading UK-based provider of non-animal immunotoxicology solutions for drug development SenzaGen AB (publ) ("SenzaGen" or...

October 12 Investing.com

Summary of SenzaGen AB's Q1/2025 earnings call

SenzaGen's stock plummeted by 14.91% following an unclear Q1 2025 earnings release that lacked precise financial metrics and guidance. Despite the decline in share price, InvestingPro data shows a gross margin of 66.89%...

August 27 Investing.com

SenzaGen AB: news and analytics

SenzaGen shares plunge after unclear Q1 2025 report Investing.com — SenzaGen AB's recent first quarter 2025 report left...

August 20 Finanznachrichten

SenzaGen AB: SenzaGen's interim report January-June 2026 | Continued strong development in Q2 2026 - 13% growth with positive cash flow

Message from the CEO "Revenue for the second quarter increased to SEK 15.3 million, corresponding to 13 % growth (18% at constant exchange rates). At...

Never miss news about SenzaGen

Track SenzaGen and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

SenzaGen competitors & trending companies

Browse news for competitors to SenzaGen and other trending companies.